Moderna announced that it would seek an emergency use authorization, or EUA, from the Food and Drug Administration on Monday after its phase three study found its coronavirus vaccine candidate to be 94% effective.

Moderna said its vaccine was 100% effective at preventing severe cases of COVID-19.

Recommended Stories

Moderna COVID-19 vaccine receives full FDA approval for adults

Pfizer study finds COVID-19 vaccine over 90% effective for children ages 5-11

COVID-19 vaccine maker BioNTech expects updated omicron-specific shots by October